| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―19 |
Association of genetic variants with the progression of COVID-19 symptoms in diabetic patients: a systematic review and in silico protein interaction analysis |
L. C. Silveira, K. F. Santos, J. S. Campos, L. P. Assunção, R. S. Santos, A. A. S. Reis |
| 2 |
[GO] |
2025―Sep―22 |
Lymphopenia as a diagnostic biomarker in clinical COVID-19: insights from a comprehensive study on SARS-CoV-2 variants |
R. Uppal, U. Saeed, R. Tahir, M. R. Uppal, A. A. Khan, C. Rahman, et al. (+5) M. S. Uppal, D. U. Ozsahin, S. S. Gilani, Y. Waheed, Z. Z. Piracha |
| 3 |
[GO] |
2025―Sep―22 |
Comparison of D-dimer levels using coagulometer and immuno-nephelometer in Covid-19 |
S. Shoukat, E. N. G. Turchan, T. I. Budhy, J. Nugraha, C. Cyuzuzo |
| 4 |
[GO] |
2025―Aug―29 |
The impact of the COVID-19 pandemic on home gardening practices in Irbid District, Jordan |
R. W. Tahtamouni, R. A. Shibli, T. S. Al-Qudah, S. Saifan, L. S. Younes |
| 5 |
[GO] |
2025―Jul―31 |
Characterization of SARS-CoV-2 variants associated with reinfection cases in Botucatu, Brazil: a comparative genomic study |
A. M. S. Kubo, R. A. Silveira, D. B. S. Figueiredo, L. A. Umezawa, K. I. Tasca, C. M. C. B. Fortaleza, et al. (+2) G. T. Valente, R. M. T. Grotto |
| 6 |
[GO] |
2025―Jul―22 |
CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19 |
D. Torres-Gonzales, E. Colona-Vallejos, L. Alzamora-Gonzales, G. Tineo Pozo, E. Chamorro Chirinos, C. Lorenzo Quito, et al. (+4) M. Aliaga Zamudio, E. Cambillo Moyano, E. E. Aguirre-Siancas, E. Ruiz Ramirez |
| 7 |
[GO] |
2025―May―26 |
Self-reported post-vaccination side effects of each of the three rounds of COVID-19 vaccinations: the case in the Eastern Province, Saudi Arabia |
H. Al-Muzafar, S. El-Ashker, S. Bah, N. Mousa, K. Motawei, R. A. Aldahhan, et al. (+2) F. Alawad, M. Al-Hariri |
| 8 |
[GO] |
2025―Jan―27 |
Cutting-edge: bionanomaterial solutions in the battle against Severe Acute Respiratory Syndrome Coronavirus 2 |
U. Saeed, R. Uppal, M. H. Najmi, I. Fazal, A. A. Khan, Z. Z. Piracha, et al. (+5) M. R. Uppal, H. N. Ijaz, D. U. Ozsahin, B. Uzun, I. Ozsahin |
| 9 |
[GO] |
2024―Nov―25 |
Drug resistance of Acinetobacter ssp. in patients with pneumonia in a Brazilian Pre-Amazon region during the pre-pandemic and pandemic periods of COVID-19 |
M. C. C. Costa, G. P. Mesquita, M. A. Silva, L. G. Araújo, B. G. Vila Nova, L. C. M. Castelo Branco, et al. (+3) R. C. S. Silva, S. G. Marques, A. G. Abreu |
| 10 |
[GO] |
2024―Oct―28 |
Spatial-temporal analysis of COVID-19 cases in the state of Alagoas |
A. Pereira-Júnior, L. Silva, G. Morais, A. Sobrinho-Neto, D. Oliveira, M. L. Sá, et al. (+8) J. Santos, H. B. G. Messias, G. C. Ferreira Júnior, M. G. S. Cavalcanti, B. P. S. Lima, A. C. Macêdo, M. C. Ribeiro, T. J. M. Rocha |
| 11 |
[GO] |
2024―Aug―07 |
Influence and presumption of the vaccine against Covid-19 in South American families |
G. G. Cotrina Cabello, L. S. Livia Cristóbal, D. J. Pariona Cervantes, G. A. Blanco Salcedo, M. L. Zevallos, L. A. Navarro, et al. (+12) N. C. Cotrina, L. E. Guadalupe, C. D. B. Faustino, J. C. Rojas Galluffi, M. M. Delgado, F. O. Huapaya Zavala, B. F. Buendia Quispe, F. A. Zenteno Ruiz, P. F. Alania Ricaldi, F. O. Areche, I. W. Alejos Patiño, U. Campos Félix |
| 12 |
[GO] |
2024―Aug―07 |
Knowledge, behavior and practices of the population during the pandemic against the transmission of SARS-CoV-2 in the state of Alagoas, Brazil |
A. P. M. Carvalho Neto, A. P. S. Lisboa, D. A. Lemos Neto, M. M. A. Tavares, M. A. Amaral, M. F. S. Moura, et al. (+13) T. M. Anjos, A. C. S. Omena, H. B. G. Messias, B. C. Omena, G. C. Ferreira Júnior, M. G. S. Cavalcanti, L. S. Arinísio, A. C. Silva, C. J. Santos Júnior, E. C. T. Oliveira, M. L. H. Sales, M. C. Ribeiro, T. J. M. Rocha |
| 13 |
[GO] |
2024―Jul―05 |
SARS-CoV-2 clearance in term of Cycle Threshold (Ct) during first two waves of COVID-19 in Pakistan: a phenomenon of delayed viral clearance post-corticosteroid treatment |
R. Uppal, U. Saeed, M. R. Uppal, A. A. Khan, M. Ahmad, Z. Z. Piracha |
| 14 |
[GO] |
2024―Mar―04 |
Analytical assessment of clinical sensitivity and specificities of pharmaceutical rapid SARS-CoV-2 detection nasopharyngeal swab testing kits in Pakistan |
U. Saeed, R. Uppal, A. A. Khan, M. R. Uppal, Z. Z. Piracha, S. R. Uppal |
| 15 |
[GO] |
2023―Jul―21 |
Use of convalescent plasma to treat COVID-19: case studies |
Stéphani Caroline Beneti, Leila Larisa Medeiros Marques, Gisely Mattos, Flávia Aparecida Reitz Cardoso |
| 16 |
[GO] |
2023―Jun―19 |
Hepatitis C virus associated ALT, AST, GGT, Bili T, HB, HBA1C, CREAT, PT, aPPT, AFP, CEA, CA 125, CA 19-9, iPTH biomarkers, computed tomography and HCV burden of disease during pre COVID-19 era (2018-2019) and post COVID-19 era (2020-2022) in Pakistan |
U. Saeed, M. R. Uppal, M. S. Uppal, R. Uppal, A. A. Khan, A. Hassan, Z. Z. Piracha |
| 17 |
[GO] |
2023―Jan―09 |
Biomedical role of L-carnitine in several organ systems, cellular tissues, and COVID-19 |
I. S. Al-Dhuayan |
| 18 |
[GO] |
2023―Jan―09 |
D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
K. S. Al-Jubury, O. Abdulmunem K, D. K. J. Alshareef, M. Al-Jubury, M. I. Jameel |
| 19 |
[GO] |
2022―Sep―09 |
Potential histopathological and immunological effects of SARS-CoV-2 on the liver |
M. M. Alnamshan |
| 20 |
[GO] |
2022―Aug―15 |
Study of innovation capacity of fisheries companies in the covid-19 pandemic crisis |
S. Dehyouri, A. Zand, M. Arfaee |
| 21 |
[GO] |
2022―May―13 |
Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols |
L. L. M. Marques, S. C. Beneti, C. Pinzon, F. A. R. Cardoso |
| 22 |
[GO] |
2022―Apr―15 |
Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study |
M. T. Khan, A. Ali, X. Wei, T. Nadeem, S. Muhammad, A. G. Al-Sehemi, Dongqing Wei |
| 23 |
[GO] |
2021―Nov―26 |
Death caused by covid-19 in top ten countries in Asia affected by covid-19 pandemic with special reference to Pakistan |
W. Khan, A.A. Khan, J. Khan, N. Khatoon, S. Arshad, P. De los Ríos Escalante |
| 24 |
[GO] |
2021―Oct―11 |
Gender-based incidence, recovery period, and mortality rate of COVID-19 among the population of district Attock, Pakistan |
R. Ejaz, M. T. Ashraf, S. Qadeer, M. Irfan, A. Azam, S. Butt, S. Bibi |
| 25 |
[GO] |
2021―Sep―03 |
A threefold approach including quantum chemical, molecular docking and molecular dynamic studies to explore the natural compounds from Centaurea jacea as the potential inhibitors for COVID-19 |
S. Muhammad, M. F. Maqbool, A. G. Al-Sehemi, A. Iqbal, M. Khan, S. Ullah, M. T. Khan |
| 26 |
[GO] |
2021―Sep―03 |
Current understanding of an Emerging Coronavirus using in silico approach: Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) |
S. Khalid, R. Siddique, S. Shaheen, M. N. Shahid, Z. Shamim, M. K. A. Khan, Ç. Ulubaş Serçe |
| 27 |
[GO] |
2020―Oct―12 |
COVID-19 interferes in the disclosure of the first Brazilian GIAHS site |
J. B. Santos, M. A. Soares, D. P. Mucida |
| 28 |
[GO] |
2020―Jun―11 |
Fighting COVID-19 |
D. M. O. Campos, C. B. S. Oliveira, J. M. A. Andrade, J. I. N. Oliveira |
| 29 |
[GO] |
2020―Jun―11 |
Water Resources of Nicaragua and COVID-19: Between panic and apathy? |
K. Vammen, S. M. Guillen |
| 30 |
[GO] |
2020―Jun―11 |
Tear down academic paywall during pandemic |
R. Costa-Pereira |
|
